Liver fibrosis, a reversible wound-healing response to chronic cellular injury, reflects a
balance between liver repair and progressive substitution of the liver parenchyma by scar …

Umbilical cord Wharton's jelly‐derived mesenchymal stem cells (WJ‐MSCs) have recently
gained considerable attention in the field of regenerative medicine. Their high proliferation …

Abstract Background Mesenchymal stem cells (MSCs) are increasingly being applied as a
therapy for liver fibrosis. Exosomes possess similar functions to their parent cells; however …

Abstract Di (2-ethylhexyl) phthalate (DEHP) is a hazardous chemical which is used as a
plasticizer in the plastic products. Lycopene (LYC) is a carotenoid that has protective roles …

Di (2-ethylhexyl) phthalate (DEHP) is a hazardous compound used as a plasticizer in plastic
products. As a natural carotenoid, lycopene (LYC) is considered an effective protective …

End‐stage liver fibrosis frequently progresses to portal vein thrombosis, formation of
oesophageal varices, hepatic encephalopathy, ascites, hepatocellular carcinoma and liver …

Accumulating evidence indicates that most primary Wharton's jelly mesenchymal stem cells
(WJ-MSCs) therapeutic potential is due to their paracrine activity, ie, their ability to modulate …

Background Liver fibrosis is a key phase that will progress to further injuries such as liver
cirrhosis or carcinoma. This study aimed to investigate whether transplantation of bone …

Drug-induced liver injury (DILI) is one of the leading causes of acute liver injury. While many
factors may contribute to the susceptibility to DILI, obese patients with hepatic steatosis are …

Abstract Mesenchymal Stem Cells (MSCs) derived Extracellular Vesicles (EVs) have
emerged as an effective candidate for amelioration of liver fibrosis. However, the effect and …